| __timestamp | BioMarin Pharmaceutical Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 302156000 | 44820000 |
| Thursday, January 1, 2015 | 402271000 | 82080000 |
| Friday, January 1, 2016 | 476593000 | 97130000 |
| Sunday, January 1, 2017 | 554336000 | 121271000 |
| Monday, January 1, 2018 | 604353000 | 153548000 |
| Tuesday, January 1, 2019 | 680924000 | 202541000 |
| Wednesday, January 1, 2020 | 737669000 | 245164000 |
| Friday, January 1, 2021 | 759375000 | 285773000 |
| Saturday, January 1, 2022 | 854009000 | 325998000 |
| Sunday, January 1, 2023 | 937300000 | 332540000 |
| Monday, January 1, 2024 | 1009025000 |
Unleashing the power of data
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: BioMarin Pharmaceutical Inc. and PTC Therapeutics, Inc., from 2014 to 2023.
BioMarin has consistently outpaced PTC Therapeutics in SG&A spending, reflecting its larger scale and broader market reach. Over the decade, BioMarin's expenses grew by approximately 210%, peaking at nearly $937 million in 2023. In contrast, PTC Therapeutics saw a more modest increase of around 640%, reaching $333 million in the same year.
This disparity highlights BioMarin's aggressive expansion strategy, while PTC Therapeutics focuses on more targeted growth. Understanding these trends provides valuable insights into each company's strategic priorities and market positioning.
SG&A Efficiency Analysis: Comparing Pfizer Inc. and BioMarin Pharmaceutical Inc.
Regeneron Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.: SG&A Expense Trends
BeiGene, Ltd. or PTC Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Opthea Limited Trends and Insights
BioMarin Pharmaceutical Inc. and Viking Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of PTC Therapeutics, Inc. and Xenon Pharmaceuticals Inc.
PTC Therapeutics, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
PTC Therapeutics, Inc. or Ligand Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of PTC Therapeutics, Inc. and Evotec SE